Cencora · Health Care
COR
$307.90
Cencora, Inc., formerly known as AmerisourceBergen, is an American drug wholesale and distribution company and a contract research organization, that was formed by the merger of Bergen Brunswig and AmeriSource in 2001. It was renamed to Cencora in 2023.Cencora公司，前身为AmerisourceBergen，是一家美国药品批发和分销公司及合同研究机构，由BergenBrunswig和AmeriSource于2001年合并而成，2023年更名为Cencora。
Mixed profile混合特征
Large cap大盘
$60B
Engine stance引擎立场2026-07-20
Constructive — building a base建设性 — 正在筑底
Trend intact — hold. Late in the cycle, so don't add here; a pullback is due.趋势完好——持有。已处周期晚期，此处不宜加仓；回调即将到来。
Key Statistics关键统计
Price价格
$307.90
17.5% below 52-week high低于52周高点 17.5%
Market Cap市值
$60B
Normal volume正常成交量
P/E Ratio市盈率
38.5x
28.9x sector median
Beta贝塔
-0.15
Moves about -0.2x the market波动幅度约为市场的 -0.2 倍
RSI (14)RSI（14）
64
Elevated偏高
Next Earnings下次财报
2026-08-05 (17d)
Volatility Rank波动率分位
77th pctile
hist. vol. percentile历史波动率分位数
Short Interest空头兴趣
2.8% of float
Performance价格表现
| Period周期 | COR | S&P 500 | vs Index对比指数 |
|---|---|---|---|
| 1 Week近1周 | +1.5% | -1.5% | Beat the index by 3.0 points跑赢指数 3.0 个百分点 |
| 1 Month近1月 | +11.1% | +0.6% | Beat the index by 10.5 points跑赢指数 10.5 个百分点 |
| 3 Months近3月 | -5.8% | +4.7% | Lagged the index by 10.5 points落后指数 10.5 个百分点 |
| 6 Months近6月 | -12.9% | +7.8% | Lagged the index by 20.7 points落后指数 20.7 个百分点 |
| Year to date年初至今 | -8.8% | +9.1% | Lagged the index by 17.9 points落后指数 17.9 个百分点 |
| 1 Year近1年 | +5.4% | +19.4% | Lagged the index by 14.0 points落后指数 14.0 个百分点 |
Technicals技术面
RSI (14)RSI（14）
64
Elevated偏高
vs 50-day相对50日均线
+10.6% vs 50-day avg
vs 200-day相对200日均线
-4.9% vs 200-day avg
Volatility rank波动率分位
77th percentile 分位
Engine reference levels — not advice引擎参考水平 — 非投资建议
Buy zone买入区间
$298.70
Don't chase above不追高于
$307.90
Stop止损
$271.30
Hold — don't add here持有 — 此处不宜加仓
Earnings财务业绩
17
days until next report天后公布财报
2026-08-05
Estimates being raised — 3 analysts预期上调 — 3 位分析师
Post-earnings drift: +2.8% (20d)财报后漂移：+2.8%（20日）
Earnings call transcripts — coming soon财报电话会议记录 — 即将上线
Valuation估值
| Multiple指标 | COR | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| P/E (trailing)市盈率（历史） | 38.54x | 28.92 | 29% |
| P/B市净率 | 31.39x | 3.52 | 3% |
| P/S市销率 | 0.19x | 3.02 | 99% |
| Earnings yield盈利收益率 | 2.59% | 2.72 | 47% |
| FCF yield自由现金流收益率 | 5.35% | 3.94 | 66% |
| Shareholder yield股东收益率 | 1.46% | 1.89 | 39% |
| EV/EBITDA企业价值/EBITDA | 17.17x | 18.21 | 56% |
| P/FCF市值/自由现金流 | 18.67x | 22.42 | 61% |
Analyst price targets — coming soon分析师目标价 — 即将上线
Financials财务数据
Revenue营业收入
5yr CAGR5年复合增速: 11.1%
Earnings Per Share每股收益
Free Cash Flow自由现金流
Margins利润率
81.4%Return on Equity股本回报率
2.0%Return on Assets资产回报率
Leverage杠杆
| Net debt / EBITDA净债务/EBITDA | 0.90 |
| Current ratio流动比率 | 0.90 |
Capital Allocation资本配置
| Buybacks (TTM)回购（TTM） | $435.5M |
| Stock-based comp股权薪酬 | $148.0M |
| Share count change (1y)股数变化（1年） | +0.3% |
Piotroski皮奥特罗斯基 5/9
Altman Z阿尔特曼Z: safe (4.8)
Watch关注
Snapshot Gauges综合指标
Valuation vs Sector估值相对行业
Roughly fair vs sector相对行业估值合理
Cheaper than 51% of its sector on blended multiples综合估值倍数低于行业内 51% 的公司
Beta市场敏感度
-0.15×
0.21×3×
Has tended to move opposite the market (factor-adjusted)经因子调整后常与大盘反向波动
Financial Health财务健康
5/9
Altman阿尔特曼: safe
Adequate financial health财务健康状况一般
Dividend分红
—
Does not pay a dividend不派发股息
Why Is It Moving为何波动
Sector / Theme行业/主题
Health Care (Equal-Weight) theme — #6 of 46 themes「医疗保健（等权）」主题 — 46 个主题中第 6 位
Macro宏观
Long-duration name into a restrictive, rising-real-rate regime → rate headwind.长久期标的进入偏紧、实际利率上行的环境→利率逆风。
Positioning持仓
Short interest changed -11.8%空头仓位变动 -11.8%
Technical技术面
UPTREND → BOTTOMING上涨趋势 → 筑底中
Options Positioning期权持仓
Market makers are net long gamma — price pinned near current level做市商净持有正伽玛，价格倾向于在当前水平附近震荡
Expected daily move预期日波动
±2.11%
Expected weekly move预期周波动
±4.71%
Call wall看涨密集区
$310
Put wall看跌密集区
$280
Gamma flip伽玛翻转
$246
25d risk reversal25d风险逆转
-4.1%
Skew: 偏斜：fear
Ownership & Smart Money持仓与聪明钱
Insider activity内部人员活动: -$12.6M net (0 buyers, 4 sellers)-$12.6M 净值（0 买家，4 卖家）
Signal History信号历史
RALLY ON
UPTREND
Jul 15, 2026
UPTREND → BOTTOMING上涨趋势 → 筑底中
BUY SETUP买入预备
Jul 10, 2026
NEARING A HIGH → BUY ZONE接近高点 → 买入区
BUY买入
Jul 10, 2026
COR weekly MACD crossed upCOR 周线MACD上穿
The weekly MACD histogram turned positive — the slower, less-whippy momentum read.周线MACD柱状图转正 — 更慢、更少来回的动量信号。
Jul 9, 2026
UPTREND → NEARING A HIGH上涨趋势 → 接近高点
TAKE PROFITS止盈
Jul 7, 2026
BUY ZONE → UPTREND买入区 → 上涨趋势
HOLD持有
Jul 7, 2026
COR RSI reached overboughtCOR RSI进入超买
RSI(14) crossed above 70 — stretched to the upside; context, not a timing trigger alone. $304.48.RSI(14)上穿70 — 上行过度；仅作背景，单独不构成择时。$304.48。
Jun 30, 2026
NEARING A HIGH → BUY ZONE接近高点 → 买入区
BUY买入
Jun 23, 2026
NEARING A LOW → UPTREND接近低点 → 上涨趋势
HOLD持有
Jun 17, 2026
UNCONFIRMED TURN → NEARING A LOW未确认转向 → 接近低点
GET READY准备
Showing last 15 of显示最近15条，共 94 signals条信号
Factor Profile因子特征
Composite factor score综合因子得分: 0.12
Value价值
+1.2
Profitability盈利能力
-0.9
Quality质量
+0.8
Investment资本投入
-0.3
Shareholder payout股东回报
-0.7
Low volatility低波动
+0.5
Low market beta低市场敏感度
+1.3
Earnings quality盈利质量
-0.3
Short interest空头兴趣
+0.6
Company Profile公司档案
Cencora, Inc., formerly known as AmerisourceBergen, is an American drug wholesale and distribution company and a contract research organization, that was formed by the merger of Bergen Brunswig and AmeriSource in 2001. It was renamed to Cencora in 2023.Cencora公司，前身为AmerisourceBergen，是一家美国药品批发和分销公司及合同研究机构，由BergenBrunswig和AmeriSource于2001年合并而成，2023年更名为Cencora。
Watch items — what could change the thesis关注项 — 可能改变论点的因素
- Capital intensity rising
Get the full picture获取完整视图
Nightly signals, options flow, and factor analysis across all S&P 500 names.每日更新的信号、期权资金流向和因子分析，覆盖所有标普500成分股。